Correlation Between Relief Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Relief Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relief Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relief Therapeutics Holding and SAB Biotherapeutics, you can compare the effects of market volatilities on Relief Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relief Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relief Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Relief Therapeutics and SAB Biotherapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Relief and SAB is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Relief Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relief Therapeutics Holding are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Relief Therapeutics i.e., Relief Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Relief Therapeutics and SAB Biotherapeutics
Assuming the 90 days horizon Relief Therapeutics is expected to generate 1.05 times less return on investment than SAB Biotherapeutics. In addition to that, Relief Therapeutics is 1.06 times more volatile than SAB Biotherapeutics. It trades about 0.11 of its total potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.12 per unit of volatility. If you would invest 271.00 in SAB Biotherapeutics on September 25, 2024 and sell it today you would earn a total of 157.00 from holding SAB Biotherapeutics or generate 57.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Relief Therapeutics Holding vs. SAB Biotherapeutics
Performance |
Timeline |
Relief Therapeutics |
SAB Biotherapeutics |
Relief Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Relief Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Relief Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relief Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.Relief Therapeutics vs. NRx Pharmaceuticals | Relief Therapeutics vs. NRX Pharmaceuticals | Relief Therapeutics vs. Pasithea Therapeutics Corp | Relief Therapeutics vs. SAB Biotherapeutics |
SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |